Loading…
New: tenders and results on WhatsApp
New: Find tenders, results and companies on WhatsApp, by text or voice note
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Status |
|---|---|---|
| 1 | Admitted-Fee/PreQual/Technical 1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 | BANGALORE | BANGALORE | KARNATAKA | 560045 | Admitted-Fee/PreQual/Technical |
Tender Value
₹10.7 Cr
EMD Value
₹50,000
Closing Date
5 May 2025, 1:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
MD, HMSCL
Plot No. 9 DHL Square, 5th Floor, Sec-22, PKL
Online Short Term Tender for the Rate Contract for two years for supply of Pegylated Recombinant Anti Haemophilic Factor VIII (rF VIII) is equivalent to Extended Half Life Factor VIII, Injection 1500 IU to Various Hospitals of Government of Haryana
2025_HBC_441594_1
318/Tend/GPA/2025-26/3/4-A
Open Tender
Miscellaneous Goods
Item-rate/Agreement basic
60 days
Plot No. 9 DHL Square, 5th Floor, Sec-22, PKL
Please refer the tender document
2 documents required · 2 mandatory
₹5,000
Yes
₹50,000
Yes
27 Oct 2025
21 Apr 2025
5 May 2025
21 Apr 2025
5 May 2025
21 Apr 2025
21 Apr 2025 - 24 Apr 2025
stage.html
html • 0.02 MB
technical_519052.pdf
cancelled_1.pdf
pdf • 0.48 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.50 MB
BOQ_519052.xls
BOQ • 0.31 MB
TenderDocument318.pdf
Additional Documents • 7.31 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .